相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
Giovanni Musso et al.
GASTROENTEROLOGY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
Devram S. Ghorpade et al.
NATURE (2018)
DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization
Fen Zhuge et al.
DIABETES (2016)
DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-kappa B activation
Takanori Shinjo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
Nina Wronkowitz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
M2 Kupffer Cells Promote M1 Kupffer Cell Apoptosis: A Protective Mechanism Against Alcoholic and Nonalcoholic Fatty Liver Disease
Jinghong Wan et al.
HEPATOLOGY (2014)
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Antonio Sica et al.
HEPATOLOGY (2014)
The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?
Marcel H. A. Muskiet et al.
NATURE REVIEWS NEPHROLOGY (2014)
A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
Jixin Zhong et al.
DIABETES (2013)
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna et al.
ENDOCRINOLOGY (2013)
CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
Sang Ah Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet
Keizo Nakaya et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice
Virginia Maina et al.
CLINICAL SCIENCE (2012)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
Shani Ben-Shlomo et al.
JOURNAL OF HEPATOLOGY (2011)
Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
Wan Huang et al.
DIABETES (2010)
Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
Gabor Firneisz et al.
PLOS ONE (2010)
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
Justin I. Odegaard et al.
CELL METABOLISM (2008)
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
David Patsouris et al.
CELL METABOLISM (2008)
Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice
Kun L. Ma et al.
HEPATOLOGY (2008)
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Naoto Matsuzawa et al.
HEPATOLOGY (2007)
Dipeptidyl peptidase IV (DDP IV) in NASH patients
Yasemin H. Balaban et al.
ANNALS OF HEPATOLOGY (2007)
Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis
Young-Sun Lee et al.
DIABETES (2007)
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes - Preclinical biology and mechanisms of action
Daniel J. Drucker
DIABETES CARE (2007)
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis
Tsuguhito Ota et al.
GASTROENTEROLOGY (2007)
NASH: a mitochondrial disease
D Pessayre et al.
JOURNAL OF HEPATOLOGY (2005)
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
MD Gorrell
CLINICAL SCIENCE (2005)
分享论文
